GSK is paying $500M upfront for rights to a series of Hengrui drugs, the latest case of a pharma company looking to a Chinese firm to build out its pipeline.

Coalition for Health AI wants to help with using AI to implement work requirements for Medicaid. Experts say that's difficult ...

Initial analyses of the Trump administration’s proposed NIH cuts neglect key aspects of their long-term economic and health ...

For over an hour, Jeff Vierstra lay still in Columbia University’s ALS clinic, as a doctor poked him ankle-to-throat with an ...

With Covid vaccines, New York state chose a “let 'er rip” public health policy rather than more stringent enforcement of ...

Millions of older Americans living in poverty are entitled to free or heavily subsidized Medicare coverage. But the new ...